IP Library Granted Patent US 9,175,041
Granted Patent B2
US 9,175,041 · App. 14/113,682 · Granted Nov 3, 2015

Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline

Inventors: George R. Pettit (Paradise Valley, AZ); Thomas Smith (Tempe, AZ); Jun-Ping Xu (Chandler, AZ); Delbert Herald (Tempe, AZ)
Assignee: Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State University
C07K7/54C07C227/18C07K5/0205G06F19/701A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,041
App. No.
14/113,682
Granted
Nov 3, 2015
Kind
B2
Abstract

The present invention relates to the crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline. The present invention also relates to processes for preparing dolamethylleuine and dolaphenvaline. The present invention further relates to computer readable medium with crystal structural data and/or information stored thereon.

Claims (7)

1. A crystal comprising dolastatin 16:

wherein said crystal is in space group P2(1); and said crystal has unit cell dimensions of a=10.844 (5) Å, b=16.133 (5) Å, c=16.050 (5) Å, α=90.000 (5°), β=104.062 (5°), γ=90.000 (5°), V=2720.4 (17) Å 3 .

2. A crystallizable composition comprising dolastatin 16, wherein the crystallizable composition forms a crystal of dolastatin 16 that is of X-ray diffraction quality and wherein said crystal is in space group P2(1); and said crystal has unit cell dimensions of a=10.844 (5) Å, b=16.133 (5) Å, c=16.050 (5) Å, α=90.000 (5°), β=104.062 (5°), γ=90.000 (5°), V=2720.4 (17) Å 3 .

3. A crystal of dolastatin 16 having the X-ray crystal structure of FIG. 1 and wherein said crystal is in space group P2(1); and said crystal has unit cell dimensions of a=10.844 (5) Å, b=16.133 (5) Å, c=16.050 (5) Å, α=90.000 (5°), β=104.062 (5°), γ=90.000 (5°), V=2720.4 (17) Å 3 .

4. A method of obtaining a crystal of dolastatin 16, wherein said crystal is in space group P2(1); and said crystal has unit cell dimensions of a=10.844 (5) Å, b=16.133 (5) Å, c=16.050 (5) Å, α=90.000 (5°), β=104.062 (5°), γ=90.000 (5°), V=2720.4 (17) Å 3 , the method comprising the steps of:

(a) combining dolastatin 16 with a crystallization solution to produce a crystallizable composition; and

(b) subjecting the crystallizable composition to conditions that promote crystallization, thereby obtaining said crystal.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 032136 FRAME: 0531. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 6, 2015
From: PETTIT, GEORGE R; SMITH, THOMAS; XU, JUN-PING; HERALD, DELBERT
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 037059/0212 →
CONFIRMATORY LICENSE Recorded Dec 8, 2014
From: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034538/0556 →
Continuity (2)
Provisional Application 61478866 · Apr 25, 2011
Related Publication 20140179897A1 · Jun 26, 2014